Back
Citius Pharmaceuticals Vs. Citius Oncology Industry Stock Comparison
Sell
46
CTXR
Citius Pharmaceuticals
Last Price:
0.33
Seasonality Move:
21.66%
Sell
1
CTOR
Citius Oncology
Last Price:
1.07
Seasonality Move:
--
Sell
46
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.39. The Score for CTXR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- CTXR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Citius Oncology (CTOR)
is a Sell
Is Citius Oncology a Buy, Sell or Hold?
- The current Citius Oncology [CTOR] share price is $1.22. The Score for CTOR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- CTOR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing selling pressure, which indicates risk of future bearish movement.
CTOR Stock Price Chart
What is Citius Oncology's stock price today?
-
The Citius Oncology share price today is $1.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTOR is experiencing selling pressure, which indicates risk of future bearish movement.
CTXR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 46.64 | Sell |
Chaikin Money Flow: | -1938218 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.35 - 0.41) | Buy |
Bollinger Bands (100): | (0.4 - 0.76) | Sell |
CTOR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 46.94 | Sell |
Chaikin Money Flow: | -41402 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.07 - 1.27) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CTXR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.39 | Sell |
20-day SMA: | 0.38 | Buy |
50-day SMA: | 0.44 | Sell |
200-day SMA: | 0.65 | Sell |
8-day EMA: | 0.41 | Sell |
20-day EMA: | 0.4 | Sell |
50-day EMA: | 0.45 | Sell |
200-day EMA: | 0.63 | Sell |
CTOR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.23 | Sell |
20-day SMA: | 1.21 | Buy |
50-day SMA: | 1.34 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 1.24 | Sell |
20-day EMA: | 1.23 | Sell |
50-day EMA: | 1.41 | Sell |
200-day EMA: | 0.1 | Buy |
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Citius Oncology Earnings Growth & CTOR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Citius Pharmaceuticals Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Citius Oncology Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |